Axonics Modulation Technologies

About Axonics Modulation Technologies

Axonics Modulation Technologies (NASDAQ:AXNX) specializes in developing and commercializing innovative neuromodulation products aimed at treating bladder and bowel dysfunction. The company's primary focus is on improving the lives of patients suffering from these conditions through advanced medical technology. Axonics has dedicated itself to research and development to continuously enhance its product offerings, aligning with its objective to set new standards in the neuromodulation industry. Their efforts are encapsulated in their Sacral Neuromodulation (SNM) system, a notable project designed to offer a minimally invasive solution to patients, showcasing the company's commitment to innovation and quality healthcare solutions.

What is Axonics Modulation Technologies known for?

Snapshot

2012

Year founded

665

Employees

Irvine, United States

Head office

Loading Map...

Operations

All Locations

Irvine, US

Products and/or services of Axonics Modulation Technologies

Sacral neuromodulation systems for bladder and bowel control.
Rechargeable sacral neuromodulation (SNM) system designed for a 15-year life.
Non-rechargeable SNM system offering a low-maintenance treatment option.
Advanced programming and patient remote control for personalized therapy management.
Innovative urethral bulking agent for stress urinary incontinence.
Comprehensive patient support services including education and training.